Several malignancies including prostate cancer, breast cancer, pancreatic ductal adenocarcinoma, multidrug resistant ovarian cancer, and metastatic gastric cancer, have all been shown to exhibit an increased expression of PGK1 [76]. This evidence concerns the gene PGK1 and pancreatic ductal adenocarcinoma.